|
Post by careful2invest on Apr 21, 2017 19:03:39 GMT -5
Ddigger's intention may be to spread fud... Registered 5 hours ago to say the same things over and over. I noticed that as well! That was an easy one to figure out, wasn't it?
|
|
|
Post by careful2invest on Apr 21, 2017 11:56:17 GMT -5
Oh come on Careful. You think you're the only one down $300K here? Suck it up man. You & I invested here heavily because we both believed in Afrezza. Well, I still do and even if I lose every last dime, someday, Afrezza will still help millions. That's what matters to me, not the $350K that I'm down, nor the 100K shares I lost in the r/s. You know what? It's only money in the end & you can't take it with you. So man-up. I've already reconciled myself to the fact that my $350K is gone. So what! I'll just go out there and earn another $350K. You can do that in this country! So stop the bitterness and get yourself going again. Al Mann had a vision, and I want nothing more than to see that vision come to bear fruit. I could care less about my $350K. I will survive nonetheless and always be grateful to simply be alive and enjoy the wonders of life! Aloha. Wow!! Bizarre is right!! You wrote, "You think you're the only one down $300k here..." My answer was in my response to Kastanes where I wrote...cut and pasted "I hear ya! And we are not alone in that F'ing boat!" So no, I do not believe that I am the only one! It's pretty clear that many of us have lost a lot of money with MNKD. Secondly, $300k is a lot of money to me! Maybe not so much to you! More power to you, if it's just a drop in the bucket for you. In addition, I realize that I can earn more, I lost more than that in 2000 in the market, and I recovered! 17 years later, losing 300k leaves more of a mark! Especially after what has transpired in my life since. $300k ends up being quite a bit! And I do not think that I am alone with this perspective either. I think what we agree on is that I too, hope that AL's dream comes to fruition. But watching ones investment get squandered due to poor management decisions also leaves a mark! AFREZZA is too good to be in this position 3 years after FDA Approval! That is the bottom line! Maybe you should place me back on ignore. I think after just now learning more of your perspective, I now understand why. Aloha! I guess...
|
|
|
Post by careful2invest on Apr 21, 2017 11:12:02 GMT -5
You have two choices 1. Sell and limit your loss 2. Stop looking and hope for a rebound. I am in the same boat. I hear ya! And we are not alone in that F'ing boat! Selling at this pps is not worth it. I am out almost $300,000 Hard to stop looking because I have invested too much money! So I will still hold out hope for a rebound, but watching MNKD ignore bashing news stories, now, not attending the ADA conference? etc, just does not make any sense to me! And here we trade for pennies... Even Makers Mark cannot fix this, but I will be giving it a shot or ten. (Pun intended)
|
|
|
Post by careful2invest on Apr 21, 2017 10:48:48 GMT -5
Will these be Matt's next words to us shareholders?... I just want to announce that we are entering these bankruptcy proceedings from a position of epic strength. No need to worry, we are very close to many deals. Then Mike C will chime in again with...Winning! I always deliver!
Got to laugh to keep from crying!
I am losing hope guys and gals!
|
|
|
Post by careful2invest on Apr 20, 2017 19:04:32 GMT -5
I would think Mike Castagna should handle any misrepresentations made by the press. I respect your thought process, and normally a representative would come forward from any company or organization to make corrections as needed when someone delivers less than truthful reports of their product or service, but unfortunately it has been a pattern of MNKD to remain silent to the bashers of their product. i have witnessed about 3 years of silence. This is far from the first time that someone has misspoken about AFREZZA. That too has hurt the brand! A REVOLUTIONARY FDA approved treatment for Diabetes and we are now trading around .20 cents a share from $10.00 or so upon approval. The business practices of MNKD Management just do not make sense!
|
|
|
Post by careful2invest on Apr 20, 2017 16:29:21 GMT -5
One very important consideration related to international sales is that most countries do not allow DTC marketing and so the marketing restrictions that are impose in the USA are often irrelevant. International government healthcare/drug agencies decide what drugs are approved for sale and how the drug information is disseminated.
Even with its current non-inferiority label, Afrezza remains the world's only available inhaled insulin. Frankly, there are certain countries where needle-phobia exists and an option like Afrezza may be rapidly adopted by physicians there.
In addition, opening sales to the world market would limit the control that BP (and the rest of the crooks) have on the market here in the USA. But this lack of addressing so many obvious untapped markets and leads by MNKD just does not make sense! MNKD's blunders are inexcusable in a field where professionalism and strategical prowess are a must! For so long, I, as well as many others kept saying that they (MNKD) have to have something bigger in the works due to the repeated, blatant actions (or non actions) that we have witnessed over the last three years. But unfortunately, to our surprise, they did not! Someone or some company has to realize the benefits and potential of AFREZZA and have the money and the stones to see it through. At this stage of the game, We can only hope!
|
|
|
Post by careful2invest on Apr 20, 2017 12:56:34 GMT -5
I really want to read this but the wall of text is making me not want to. Any chance you can go back and just edit it with some paragraphs? Just a request i'm thinking others might share as well. Granted, paragraphs would have been nice, but muscle through it, it's not so tough, the guy makes a few very good points. Unfortunately, this is happening all over. And here we are at .20/share. MNKD Needs to get their act together! JDRF...Where are you?? Matt, Mike, the silence is killing the product (AFREZZA)
|
|
|
Post by careful2invest on Apr 20, 2017 9:17:46 GMT -5
Well that was the worst thing ever I agree. obviously misinformed! And how about that sh it eating grin on the doctors face? It's almost as if he knows what he is saying is total bs. Can or should MNKD contact that station for a correction story to follow up on the mis statements of this doctor? That would be free press... In addition to correcting the misleading nature of the original story. Correctly presenting AFREZZA to the masses. Is that asking too much?
|
|
|
Post by careful2invest on Apr 20, 2017 7:43:16 GMT -5
If you read that short article you'll find that the CEO of that pharma wrote that Deerfield helped them restructure their financing so that they got a better buyout price. Yes I read the linked article (from the Deerfield website) that not so surprisingly... paints Deerfield as being the good guys. Shocking they would do this on their own website no? As for this applying to MNKDs particular situation: Apples to toasters. And MNKD is kind of toast... Not yet.
|
|
|
Post by careful2invest on Apr 20, 2017 7:17:27 GMT -5
The list was for Insulin Management Systems, or key insulin players and would be correct based on insulin market share. It was not a list of forthcoming inhaled insulin players. Yet in the article, they write... "use of inhaled insulins are expected to have larger share in insulin management system market. Inhaled insulin is easy to administer, fast acting and is eliminated from body in less time. Thus, insulin that is affordable, easy to administer, readily available, fast acting with long lasting effect and quick elimination from body is expected to hold strong position in insulin management system market. But no mention of AFREZZA by name. What other "key players" are in the "inhaled insulin" market? It just does not make sense!
|
|
|
Post by careful2invest on Apr 19, 2017 16:53:15 GMT -5
Insulin Management System Market Volume Forecast and Value Chain Analysis 2016-2026 April 19th, 2017
Excerpt:
Insulin Management System Market: Overview
Insulin treatment for Type II diabetes holds largest share due to its high prevalence and also availability of variety and advances in insulin management systems available to treat type II diabetes. Also in comparison to recombinant human Insulin there is greater share for insulin analogues due to its higher efficacy with fast and long lasting effects. Moreover in comparison to painful traditional methods of insulin administration by injections, use of inhaled insulins are expected to have larger share in insulin management system market. Inhaled insulin is easy to administer, fast acting and is eliminated from body in less time. Thus, insulin that is affordable, easy to administer, readily available, fast acting with long lasting effect and quick elimination from body is expected to hold strong position in insulin management system market.
Insulin Management System Market: Regional Overview
Region wise, the global regions in Insulin Management System market is classified into, North America, Latin America, Western and Eastern Europe, Asia-Pacific (excluding Japan) and MEA (Brazil, Argentina, Nigeria, Saudi Arabia & Egypt).
Source: www.medgadget.com/2017/04/insulin-management-system-market-volume-forecast-and-value-chain-analysis-2016-2026.html
- America dominates the global insulin management system market due to higher prevalence of diabetes, high income population and also due to significant patent protection for brands of biosimilar insulin.
- Europe holds second largest insulin management system market due to better distribution network for key players in insulin management system market.
- Asia Pacific and MEA are the fastest growing due to adoption of various advancement in insulin management system. Initiatives taken by government in developing countries to provide better healthcare facilities and easy utilization of insulin management system plays a larger role in increasing market for insulin management systems.
Mannkind is not listed as a key player. Are they expecting one of the BPs to have an inhaled insulin product approved in these markets? Again...It just does not make sense! That's MNKD
|
|
|
Post by careful2invest on Apr 19, 2017 12:04:28 GMT -5
liane, I'm shocked, you've become such a skeptic!! Past history is no indication of future performance! Liane, are you applying "past history is no indication of future performance" to you, or to Deerfield?
|
|
|
Post by careful2invest on Apr 9, 2017 13:07:38 GMT -5
Love the "I've been taking a few hits from the bong filled with hopium for quire some time now" line Sports! Thats was doubly creative. You may want to consider writing a book about your life! Yes I agree, the best to all true Longs! Aloha. ILovekauai, Due to it not being a big deal, but just to keep the record straight, I tried to send you a dm just to let you know that the quote about the toke from the hopium bong was mine. But my Dm was rejected because you have me blocked. Blocked, REALLY? Oh well, your choice... At any rate, thanks for the compliment! GLTA TRUE LONGS!!
|
|
|
Post by careful2invest on Apr 9, 2017 12:51:15 GMT -5
You may be right. And still we can merely speculate...so I will... How many of us that realize the benefits and potential of AFREZZA have said (or thought) that we cannot believe that someone with deep pockets and a vision has not swooped in to take AFREZZA to the masses. This is what I believe may be taking place. Yes, it will take a great deal of money, but the return on investment would be huge! Why wouldn't they? AFREZZA is revolutionary. It is second only to a healthy human pancreas, etc. etc...We all know the benefits. MNKD has done most of the heavy lifting...They have developed an FDA Approved drug that works and works very well! Once enough people are exposed to it, It will naturally take a lead as the best treatment of Diabetes known to man. I admit, I have been taking a few tokes from the bong filled with hopium for quite some time now. But it would be hard to believe that something so beneficial to so many (Afrezza) can get squashed by greed and politics. I know that it can happen, and often does, but I have more hope than that for Mankind, Mannkind, as well as my investment! Either way, we are getting closer to a verdict one way or the other! GLTA TRUE LONGS!! Agree, check this out:-) It's the new thing.. I realize that this is months old, and granted, any talk about AFREZZA is a good thing, But my initial take is there is a lot of room for refinement. It is like a rough draft of a paper that you had to write in High school. It is not very thourough or concise in sending the message that needs sent to the masses about AFREZZA. Hopefully, the message about AFREZZA from Damon is getting refined. I am sure that his knowledge and comfort in using AFREZZA has improved since this video was made and that will most likely come through in the current and future work that he does for the promotion of AFREZZA. GLTA TRUE LONGS!
|
|
|
Post by careful2invest on Apr 9, 2017 12:19:50 GMT -5
Another possibility is that maybe Claude Mann has had enough. She gave Matt some time to get sales moving with the hiring of Castagna and wants a shake up in management due to the lack of progress and agreed to allow them to update the CoC. This was my first thought. ^ Second was another BP buying us for a low pps. If we can sell Afrezza in the next few months that might change. So I hope the shareholders meeting comes and goes... You may be right. And still we can merely speculate...so I will... How many of us that realize the benefits and potential of AFREZZA have said (or thought) that we cannot believe that someone with deep pockets and a vision has not swooped in to take AFREZZA to the masses. This is what I believe may be taking place. Yes, it will take a great deal of money, but the return on investment would be huge! Why wouldn't they? AFREZZA is revolutionary. It is second only to a healthy human pancreas, etc. etc...We all know the benefits. MNKD has done most of the heavy lifting...They have developed an FDA Approved drug that works and works very well! Once enough people are exposed to it, It will naturally take a lead as the best treatment of Diabetes known to man. I admit, I have been taking a few tokes from the bong filled with hopium for quite some time now. But it would be hard to believe that something so beneficial to so many (Afrezza) can get squashed by greed and politics. I know that it can happen, and often does, but I have more hope than that for Mankind, Mannkind, as well as my investment! Either way, we are getting closer to a verdict one way or the other! GLTA TRUE LONGS!!
|
|